218 related articles for article (PubMed ID: 37833332)
1. PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer.
Peng J; Li P; Li Y; Quan J; Yao Y; Duan J; Liu X; Li H; Yuan D; Wang X
Sci Rep; 2023 Oct; 13(1):17399. PubMed ID: 37833332
[TBL] [Abstract][Full Text] [Related]
2. PFKP is highly expressed in lung cancer and regulates glucose metabolism.
Shen J; Jin Z; Lv H; Jin K; Jonas K; Zhu C; Chen B
Cell Oncol (Dordr); 2020 Aug; 43(4):617-629. PubMed ID: 32219704
[TBL] [Abstract][Full Text] [Related]
3. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 4 (KLF4) activates the transcription of the gene for the platelet isoform of phosphofructokinase (PFKP) in breast cancer.
Moon JS; Kim HE; Koh E; Park SH; Jin WJ; Park BW; Park SW; Kim KS
J Biol Chem; 2011 Jul; 286(27):23808-16. PubMed ID: 21586797
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.
Umar SM; Kashyap A; Kahol S; Mathur SR; Gogia A; Deo SVS; Prasad CP
Exp Cell Res; 2020 Nov; 396(1):112282. PubMed ID: 32919954
[TBL] [Abstract][Full Text] [Related]
6. Phosphofructokinase 1 platelet isoform induces PD-L1 expression to promote glioblastoma immune evasion.
Wang S; Park SH; Lim JS; Park YY; Du L; Lee JH
Genes Genomics; 2022 Dec; 44(12):1509-1517. PubMed ID: 35917090
[TBL] [Abstract][Full Text] [Related]
7. PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer.
Yeerken D; Hong R; Wang Y; Gong Y; Liu R; Yang D; Li J; Fan J; Chen J; Zhang W; Zhan Q
PLoS One; 2020; 15(5):e0233750. PubMed ID: 32470015
[TBL] [Abstract][Full Text] [Related]
8. Phosphofructokinase 1 Platelet Isoform Enhances VEGF Expression in Part Through HIF-1α Up-regulation in Breast Cancer.
Lee JH
Anticancer Res; 2023 Jan; 43(1):75-84. PubMed ID: 36585185
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Roles of Phosphofructokinase Platelet in Clear Cell Renal Cell Carcinoma and Correlation with Immune Infiltration.
Liu B; Li F; Liu M; Xu Z; Gao B; Wang Y; Zhou H
Int J Gen Med; 2021; 14():3645-3658. PubMed ID: 34321910
[TBL] [Abstract][Full Text] [Related]
11. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
[TBL] [Abstract][Full Text] [Related]
12. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
13. Platelet isoform of phosphofructokinase accelerates malignant features in breast cancer.
Inaishi T; Shibata M; Ichikawa T; Kanda M; Hayashi M; Soeda I; Takeuchi D; Takano Y; Tsunoda N; Kodera Y; Kikumori T
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751415
[TBL] [Abstract][Full Text] [Related]
14. Phosphofructokinase Platelet Overexpression Accelerated Colorectal Cancer Cell Growth and Motility.
Lu TJ; Yang YF; Cheng CF; Tu YT; Chen YR; Lee MC; Tsai KW
J Cancer; 2023; 14(6):943-951. PubMed ID: 37151384
[No Abstract] [Full Text] [Related]
15. Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma.
Zhang D; Jiang Z; Hu J; Sun X; Zheng Y; Shen Y
Front Immunol; 2023; 14():1117585. PubMed ID: 37251370
[TBL] [Abstract][Full Text] [Related]
16. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer.
Pan T; Wang S; Wang Z
J Cancer; 2023; 14(10):1809-1836. PubMed ID: 37476180
[No Abstract] [Full Text] [Related]
18. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
19. PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer.
Zhao R; Chen S; Cui W; Xie C; Zhang A; Yang L; Dong H
Front Immunol; 2023; 14():1232047. PubMed ID: 37936713
[TBL] [Abstract][Full Text] [Related]
20. Pancancer Analysis of Revealed
Cui J; Tian Y; Liu T; Lin X; Li L; Li Z; Shen L
Dis Markers; 2022; 2022():5447017. PubMed ID: 36118672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
